XRF SCIENTIFIC LIMITED 13 December 2018
The Company Secretary XRF Scientific Limited 98 Guthrie Street, Osborne Park WA 6017
Fax: (08) 9244 9611
Dear Mr Watson
Notice of ceasing to be a substantial holder
We enclose Corporations Act 2001 Form 605, Notice of ceasing to be a substantial holder, lodged today with the Australian Securities Exchange.
Yours faithfully
I.D. Bloodworth Company Secretary
605
page 1/2
15 July 2001
Form 605
Corporations Act 2001
Section 671B
Notice of ceasing to be a substantial holder
ToCompany Name/SchemeXRF Scientific Limited (XRF)
ACN/ARSN
ACN 107 908 314
1. Details of substantial holder (1)
Name
ACN/ARSN (if applicable)Washington H. Soul Pattinson and Company Limited (WHSP)ACN 000 002 728
The holder ceased to be a substantial holder on The previous notice was given to the company on The previous notice was dated
2. Changes in relevant interests
11/12/2018 10/03/2017 10/03/2017
Particulars of each change in, or change in the nature of, a relevant interest (2) of the substantial holder or an associate (3) in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:
Date of change | Person whose relevant interest changed | Nature of change (4) | Consideration given in relation to change (5) | Class (6) and number of securities affected | Person's voted affected | |
16/05/2018 | WHSP(due to holding voting power of more than 20% in Pengana Capital Group (PCG)) | Sale | $14,901 | -90,411 | ordinary shares | -90,411 |
07/11/2018 | WHSP as above | Sale | $26,985 | -180,000 | ordinary shares | -180,000 |
08/11/2018 | WHSP as above | Sale | $300 | -2,000 | ordinary shares | -2,000 |
12/11/2018 | WHSP as above | Sale | $17,490 | -116,666 | ordinary shares | -116,666 |
19/11/2018 | WHSP as above | Sale | $21,988 | -146,666 | ordinary shares | -146,666 |
20/11/2018 | WHSP as above | Sale | $13,992 | -93,333 | ordinary shares | -93,333 |
22/11/2018 | WHSP as above | Sale | $28,334 | -189,000 | ordinary shares | -189,000 |
26/11/2018 | WHSP as above | Sale | $7,496 | -50,000 | ordinary shares | -50,000 |
04/12/2018 | WHSP as above | Sale | $13,381 | -92,335 | ordinary shares | -92,335 |
06/12/2018 | WHSP as above | Sale | $9,095 | -65,000 | ordinary shares | -65,000 |
10/12/2018 | WHSP as above | Sale | $4,870 | -33,606 | ordinary shares | -33,606 |
11/12/2018 | WHSP as above | Sale | $28,484 | -200,000 | ordinary shares | -200,000 |
605
page 2/2
15 July 2001
3. Changes in association
The persons who have become associates (3) of, ceased to be associates of, or have changed the nature of their association (7) with, the substantial holder in relation to voting interests in the company or scheme are as follows:
Name and ACN/ARSN (if applicable) | Nature of association |
4. Addresses
The addresses of persons named in this form are as follows:
Name | Address |
WHSP | Level 1, 160 Pitt Street Mall, Sydney NSW 2000 |
PCG | Level 12, 167 Macquarie Street, Sydney NSW 2000 |
Signature
print nameIan David Bloodworth
capacityCompany Secretary
sign here
date
13/12/2018
DIRECTIONS
(1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 4 of the form.
(2) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.
(3) See the definition of "associate" in section 9 of the Corporations Act 2001.
(4) Include details of:
(a) any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and
(b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).
See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.
(5) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.
(6) The voting shares of a company constitute one class unless divided into separate classes.
(7) Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.
Attachments
- Original document
- Permalink
Disclaimer
XRF Scientific Limited published this content on 13 December 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 13 December 2018 08:29:03 UTC
